IRRAS AB publishes Year End Report for the period January to December 2021
Sixth Consecutive Quarter of Revenue Growth Posted“The 4th quarter of 2021 served as an encouraging end to an eventful year for our IRRAS team. Each consecutive quarter of 2021 showed the progress that IRRAS is making toward becoming a leader in neurocritical care, and we are poised to continue this progress into 2022.” “All told, we are pleased with our accomplishments throughout all of 2021. During the year, our team progressed across all aspects of our business, and these accomplishments resulted in revenue growth of more than 200% during 2021.” Will Martin, President and CEO of